Penumbra, Inc.
(NYSE : PEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 0.47%23.386.3%$1311.41m
TMOThermo Fisher Scientific, Inc. -1.32%382.561.0%$555.58m
DXCMDexCom, Inc. -0.20%439.648.2%$525.71m
MDTMedtronic Plc 0.77%90.820.6%$523.27m
BDXBecton, Dickinson & Co. -0.50%257.331.0%$495.38m
ABTAbbott Laboratories -0.67%93.040.8%$494.90m
DHRDanaher Corp. -0.95%183.700.7%$446.67m
BSXBoston Scientific Corp. 0.52%34.681.0%$429.44m
QDELQuidel Corp. 0.69%246.647.7%$412.12m
ISRGIntuitive Surgical, Inc. 0.24%575.872.4%$333.95m
SYKStryker Corp. 0.07%177.891.3%$308.55m
BAXBaxter International, Inc. -0.53%85.241.8%$275.66m
ALGNAlign Technology, Inc. -0.29%273.296.4%$224.28m
ZBHZimmer Biomet Holdings, Inc. 1.52%119.431.7%$205.29m
BIOBio-Rad Laboratories, Inc. -0.03%477.902.9%$199.18m

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.